Basic Study
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo

World J Gastrointest Pathophysiol
14(4):71-85.
Published online Aug 24, 2023.
doi: 10.4291/wjgp.v14.i4.71
Abstract (918)
|
Core Tip (993)
|
Article Highlights (1007)
|
Full Article (HTML) (3306)
|
Figures (1-6) (535)
|
Tables (1-1) (599)
|
Full Article (PDF)-1730K (275)
|
Full Article with Cover (PDF)-1973K (197)
|
Full Article (XML)-137K (139)
|
Audio-875K (11)
|
Peer-Review Report-314K (136)
|
Answering Reviewers-148K (140)
|
Supplementary Material-220K (152)
|
Received: 06/01/2023
|
Revised: 08/02/2023
|
Accepted: 08/07/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (12228)
|
Similar Articles (0)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open